TrialJournal of Parkinson's disease2020

EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease.

Caroline M Tanner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.